CD8A and neoplasm: Apart from that, butyric acid enhances the immune system's attack on tumor cells by inhibiting histone deacetylases (HDACs) and promoting the expression of effector molecules, such as IFN-γ and granzyme B, in CD8 + cytotoxic T lymphocytes (CTLs).